Zobrazeno 1 - 10
of 68
pro vyhledávání: '"B Quiambao"'
Autor:
B. Quiambao, C. Ambas, S. Diego, V. Bosch Castells, J. Korejwo, C. Petit, A. Rasuli, G. Houillon
Publikováno v:
International Journal of Infectious Diseases, Vol 101, Iss , Pp 531- (2020)
Externí odkaz:
https://doaj.org/article/239df58cad204abfa1066e5ae8c7ec67
Autor:
Elizabeth A Pearsall, Rui Cheng, Satoshi Matsuzaki, Kelu Zhou, Lexi Ding, Bumsoo Ahn, Michael Kinter, Kenneth M Humphries, Alexander B Quiambao, Rafal A Farjo, Jian-Xing Ma
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0208399 (2019)
Diabetic retinopathy (DR) is a common neurovascular complication of type 1 diabetes. Current therapeutics target neovascularization characteristic of end-stage disease, but are associated with significant adverse effects. Targeting early events of DR
Externí odkaz:
https://doaj.org/article/f7a3f67e744b4e8dacc88006e3b0edac
Autor:
Jovigail P Bermejo, Claudette Marie N Verano, Beatrice Ann B Quiambao, Shayne Aira B Baguingan, Karla Joyce R Saldaña, Mary Louise L Cartina, Patricia E Bondoc, Romulo R Macadangdang, Dinalyn M Ugay, Anjelo Nazarene S Liwa
Publikováno v:
Asian Journal of Biological and Life sciences. 10:280-290
Autor:
Xi-Qin Ding, Alexander B Quiambao, J Browning Fitzgerald, Mark J Cooper, Shannon M Conley, Muna I Naash
Publikováno v:
PLoS ONE, Vol 4, Iss 10, p e7410 (2009)
Subretinal delivery of polyethylene glycol-substituted lysine peptide (CK30PEG)-compacted DNA nanoparticles results in efficient gene expression in retinal cells. This work evaluates the ocular safety of compacted DNA nanoparticles. CK30PEG-compacted
Externí odkaz:
https://doaj.org/article/7961d501e2434284ab3237479c1a5dad
Publikováno v:
PLoS ONE, Vol 1, p e38 (2006)
The eye is an excellent candidate for gene therapy as it is immune privileged and much of the disease-causing genetics are well understood. Towards this goal, we evaluated the efficiency of compacted DNA nanoparticles as a system for non-viral gene t
Externí odkaz:
https://doaj.org/article/e6f45367c3b44182a5ea86c510b68ce9
Autor:
Michael Kinter, Jian Xing Ma, Alexander B. Quiambao, Lexi Ding, Rafal Farjo, Kelu Zhou, Elizabeth A. Pearsall, Rui Cheng, Kenneth M. Humphries, Satoshi Matsuzaki, Bumsoo Ahn
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 2, p e0208399 (2019)
PLoS ONE, Vol 14, Iss 2, p e0208399 (2019)
Diabetic retinopathy (DR) is a common neurovascular complication of type 1 diabetes. Current therapeutics target neovascularization characteristic of end-stage disease, but are associated with significant adverse effects. Targeting early events of DR
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Translational Vision Science & Technology
Purpose To determine if a Microemulsion Drug Ocular Penetration System (MiDROPS) formulation of cyclosporine A (CsA) delivers more drug and is more efficacious for treatment of dry eye disease (DED) than the current clinical formulation. Methods Tiss
Autor:
Phillip Vanlandingham, Alexander Yeganeh, Qilong Wang, Gennadiy Moiseyev, Ashley Martin, Laura Otalora, Krysten M. Farjo, Mei Du, Alexander B. Quiambao, Rafal Farjo
Publikováno v:
Molecular and Cellular Biology. 35:2771-2789
Serum retinol-binding protein 4 (RBP4) is the sole specific transport protein for retinol in the blood, but it is also an adipokine with retinol-independent, proinflammatory activity associated with obesity, insulin resistance, type 2 diabetes, and c
Autor:
Rafal Farjo, Krysten M. Farjo, Jian Xing Ma, Alexander B. Quiambao, R. A. Wassel, Phillip Vanlandingham, Didier J. Nuno, Eric D. Phelps
Publikováno v:
Investigative Ophthalmology & Visual Science
Purpose Diabetic retinopathy is a leading cause of vision loss. Previous studies have shown signaling pathways mediated by Stat3 (signal transducer and activator of transcription 3) play a primary role in diabetic retinopathy progression. This study